Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
On April 27, 2021, the Board of Directors of AngioSoma, Inc. (the “Company”)
elected Brooke Greenwald as Chief Marketing Officer of the corporation.
Ms. Greenwald founded Cornerstone Communications, LTD over two decades
ago. As an award-winning public relations, marketing and communications professional, Ms. Greenwald has written for hundreds of publications,
created content for many of today’s most recognizable companies and their brands, managed full marketing campaigns, created and
implemented major public relations and communications campaigns, and worked for some of the largest news organizations in existence today.
She has focused her career on healthcare, technology, security, and communications. Greenwald is a former journalist and has worked inside
most of the major news networks. Ms. Greenwald holds a master’s degree in Public Relations from the University of Maryland at College
Park.
On April 27, 2021, the Board of Directors of the Company elected Steven
F. Penderghast as Director of the corporation.
Mr. Penderghast has spent the past three decades focused on clinical and
product development, market development and commercialization of medical devices, capital equipment and biologics. His roles have included:
clinical and regulatory affairs, product development, market development, sales management, national contracts, and corporate account
management. Most recently, Steven served as Corporate Vice President, Health Systems & National Accounts with Becton Dickinson, Inc.
He has marketed technologies in the areas of: Vascular and Oncology Drug Delivery, Tumor Ablation, Oncology Therapeutics, Cardiovascular
Intervention, Imaging, Urology, General Surgery, and Diagnostics. Mr. Penderghast is a graduate of Pepperdine University, California.
On May 6, 2021, the Board of Directors of the Company elected David Croom
as Executive Vice President of the corporation.
Mr. Croom is an executive management leader and entrepreneur and has broad
experience with business processes. Leveraging 30+ years of experience in both large and small companies gives Croom a unique perspective
with respect to the regulatory, financial, operational, and personnel-related issues faced by public companies. Mr. Croom is an effective
networker and speaker who has consistently worked with everyone from Wall Street to Main Street.
On May 6, 2021, the Board of Directors of the Company elected Dr. Leonard
Wisneski, MD, FACP as the Medical Advisory Board Chairman.
Dr. Wisneski is Clinical Professor of Medicine at George Washington University,
Adjunct Faculty in the Department of Biochemistry and Molecular Biology at Georgetown University and also holds faculty positions in the
Medicine and Nursing Departments at The University of Colorado. His medical practice in endocrinology and integrative medicine, spanning
three decades, embodies the true meaning of integrative healthcare – an optimal combination of conventional and complementary medicine
practiced with a whole-person approach delivered with reverence and humanism. Dr. Wisneski graduated from Thomas Jefferson Medical College
and performed his postgraduate training in the field of Internal Medicine and Endocrinology in the George Washington University healthcare
system, where he served as Chief Medical Resident in Internal Medicine.